Seroatlas · Human Serome Atlas

MATK

Megakaryocyte-associated tyrosine-protein kinase

Also known as: CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MATK_HUMAN, MGC1708, MGC2101

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P42679
Gene
MATK
Ensembl
ENSG00000007264
Chromosome
19
Canonical length
507 aa
Protein class
Cancer-related genes, Enzymes, Predicted intracellular proteins
Subcellular location
Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol

OverviewNCBI Gene

The protein encoded by this gene has amino acid sequence similarity to Csk tyrosine kinase and has the structural features of the CSK subfamily: SRC homology SH2 and SH3 domains, a catalytic domain, a unique N terminus, lack of myristylation signals, lack of a negative regulatory phosphorylation site, and lack of an autophosphorylation site. This protein is thought to play a significant role in the signal transduction of hematopoietic cells. It is able to phosphorylate and inactivate Src family kinases, and may play an inhibitory role in the control of T-cell proliferation. This protein might be involved in signaling in some cases of breast cancer. Three alternatively spliced transcript variants that encode different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

507 residues, UniProt reviewed canonical sequence.

>P42679|MATK
     1  MAGRGSLVSW RAFHGCDSAE ELPRVSPRFL RAWHPPPVSA RMPTRRWAPG TQCITKCEHT
    61  RPKPGELAFR KGDVVTILEA CENKSWYRVK HHTSGQEGLL AAGALREREA LSADPKLSLM
   121  PWFHGKISGQ EAVQQLQPPE DGLFLVRESA RHPGDYVLCV SFGRDVIHYR VLHRDGHLTI
   181  DEAVFFCNLM DMVEHYSKDK GAICTKLVRP KRKHGTKSAE EELARAGWLL NLQHLTLGAQ
   241  IGEGEFGAVL QGEYLGQKVA VKNIKCDVTA QAFLDETAVM TKMQHENLVR LLGVILHQGL
   301  YIVMEHVSKG NLVNFLRTRG RALVNTAQLL QFSLHVAEGM EYLESKKLVH RDLAARNILV
   361  SEDLVAKVSD FGLAKAERKG LDSSRLPVKW TAPEALKHGK FTSKSDVWSF GVLLWEVFSY
   421  GRAPYPKMSL KEVSEAVEKG YRMEPPEGCP GPVHVLMSSC WEAEPARRPP FRKLAEKLAR
   481  ELRSAGAPAS VSGQDADGST SPRSQEP

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against MATK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.32
Highest tissue expression
56 nTPM

Expression across tissuesHPA

Tissue

  • cerebral cortex: 56 nTPM
  • hippocampal formation: 54 nTPM
  • amygdala: 45 nTPM
  • basal ganglia: 36 nTPM
  • hypothalamus: 20 nTPM
  • bone marrow: 19 nTPM

Single-cell type

  • tuft cells: 496 nCPM
  • nk-cells: 180 nCPM
  • t-cells: 67 nCPM
  • megakaryocyte-erythroid progenitors: 45 nCPM
  • megakaryocyte progenitors: 43 nCPM
  • innate lymphoid cells: 38 nCPM

Immune cell

  • NK-cell: 77 nTPM
  • gdT-cell: 46 nTPM
  • MAIT T-cell: 31 nTPM
  • memory CD8 T-cell: 29 nTPM
  • naive CD8 T-cell: 17 nTPM
  • total PBMC: 7.6 nTPM

Brain region

  • cerebral cortex: 91 nTPM
  • hippocampal formation: 58 nTPM
  • white matter: 52 nTPM
  • basal ganglia: 42 nTPM
  • amygdala: 41 nTPM
  • hypothalamus: 33 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.77
gnomAD pLI
0
gnomAD missense Z
1.81
DepMap mean gene effect
-0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of MATK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads MATK as an antibody target. Whether an autoantibody or antibody against MATK could matter depends on whether native MATK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

MATK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label MATK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/MATK. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...